Evidence map›Paper›PMID 23266935›Full record

ArticleThe Journal of physiology2013

α(1A)-Adrenergic regulation of inhibition in the olfactory bulb.

Nathan C Zimnik, Tyler Treadway, Richard S Smith, Ricardo C Araneda

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03775096 phase2active not recruitingnot on this mapstarted 2019, after this paper: background citation

The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease

TypeinterventionalSponsorMichele Tagliati, MDRan2019 to 2026Enrolled15ConditionsREM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson DiseaseArmsCarvedilol
NCT05109364 phase2active not recruitingnot on this mapstarted 2022, after this paper: background citation

The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2022 to 2026Enrolled15ConditionsSymptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's DiseaseArmsTerazosin therapy
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Crosstalk of noradrenergic CaCell communication and signaling : CCS · 2026
    Article
  2. iScience · 2023
    Article
  3. αFrontiers in cellular neuroscience · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. αFrontiers in pharmacology · 2020
    Review
  9. Spatial Structure of Synchronized Inhibition in the Olfactory Bulb.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Differential Muscarinic Modulation in the Olfactory Bulb.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  17. Drug-target based cross-sectional analysis of olfactory drug effects.European journal of clinical pharmacology · 2015
    Article
  18. Article
  19. Disruption of centrifugal inhibition to olfactory bulb granule cells impairs olfactory discrimination.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nathan C ZimnikDepartment of Biology, University of Maryland, College Park, MD 20742, USA.
Tyler Treadway
Richard S Smith
Ricardo C Araneda
University of Maryland, College Park · US

Funding

Neuromodulation in the olfactory systemR01DC009817 · NIDCD · UNIV OF MARYLAND, COLLEGE PARK · PI ARANEDA, RICARDO C · 2010 to 2014
$1.8M
Howard Hughes Medical InstituteNIDCD NIH HHS R01 DC009817PHS HHS DCRO1-DC-009817
6 · The paper itself

Abstract

By regulating inhibition at dendrodendritic synapses between mitral and granule cells (GCs), noradrenergic neurons extending from the brainstem provide an input essential for odour processing in the olfactory bulb (OB). In the accessory OB (AOB), we have recently shown that noradrenaline (NA) increases GABA inhibitory input on to mitral cells (MCs) by exciting GCs. Here, we show that GCs in the main OB (MOB) exhibit a similar response to NA, indicating a common mechanism for noradrenergic regulation of GCMC inhibition throughout the OB. In GCs of the MOB, NA (10 μM) produced a robust excitatory effect that included a slow afterdepolarization that followed a train of action potentials evoked by a current stimulus. The depolarization and slow afterdepolarization in GCs were blocked by the α1A-adrenergic receptor (AR) selective antagonist WB 4101 (30 nm) and mimicked by the α(1A)-AR selective agonist A 61603 (1 μM). In recordings from MCs, A 61603 (30 nm-1 μM) produced a sizeable increase in the frequency of spontaneous and miniature IPSCs, an effect completely abolished by the GABAA receptor antagonist gabazine (5 μM). Likewise, activation of β-ARs increased the frequency of spontaneous IPSCs; however, this effect was smaller and confined to the first postnatal weeks. NA enhanced inhibition in MCs across a broad concentration range (0.1-30 μM) and its effects were completely abolished by a mixture of α1- and β-AR antagonists (1 μM prazosin and 10 μM propranolol). Furthermore, the general α2-AR agonist clonidine (10 μM) failed to affect sIPSC frequency. Thus, the NA-mediated increase in GCMC inhibition in the OB results mostly from activation of the α1A-AR subtype.

Indexed as

Adrenergic alpha-AgonistsAnimalsInhibitory Postsynaptic PotentialsMiceMice, Inbred C57BLNeuronsNorepinephrineOlfactory BulbReceptors, Adrenergic, alpha-1SynapsesAdrenergic alpha-AgonistsNorepinephrineReceptors, Adrenergic, alpha-1

Identifiers

PMID23266935
PMCPMC3624843
OpenAlexW1481544626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.